Leigh Burchell, Allscripts Vice President, Policy & Government Affairs, receives HIMSS21 Most Influential Women in Health IT ...
June 14 2021 - 4:01PM
Business Wire
HIMSS has announced Leigh Burchell, Allscripts Vice President,
Policy and Government Affairs, as a recipient of the HIMSS21 Most
Influential Women in Health IT Award.
The Most Influential Women in Health IT Awards recognize and
celebrate influential female leaders who harness the power of
information and technology to transform health and healthcare. The
winners are unique among power lists and award programs, and they
are inclusive of all women of influence, no matter where they may
be in the health information and technology field.
Burchell directs the Policy and Government Affairs function for
Allscripts, including legislative advocacy and regulatory
interpretation and comment. She is also active in many industry
associations, including the Electronic Health Record Association
(EHRA) as a past Chair and current leader of the Public Policy
Workgroup; the eHealth Initiative, where she sits on the Leadership
Council and the Policy Steering Committee; and HIMSS, where she is
an active participant in the Public Policy Committee. She has
relationships across the industry and experience on topics ranging
from information exchange to the digital intersections between
health equity and social determinants of health, information
blocking to how health IT can assist with the opioid crisis.
Burchell will be recognized during the 2021 HIMSS Global
Conference & Exhibition, held August 9-13, 2021 in Las Vegas,
Nevada at the Venetian-Sands Expo Center.
“I appreciate HIMSS’ recognition of my hard work, and it’s been
a pleasure to partner with them on numerous initiatives over my two
decades at Allscripts,” said Burchell. “I admittedly tend to go on
a bit when talking about opportunities for patients and healthcare
as a whole now that health IT solutions are largely ubiquitous, but
it is something I genuinely get excited about. So many people in my
life – and me as a breast cancer survivor – have benefitted because
our clinicians had a fuller picture when we were being treated,
thanks to an EHR.”
Burchell continued, “The fact that health data can now be used
to assess whole populations for necessary interventions or,
conversely, to consider an individual’s most personalized genetic
information during their treatment, is remarkable. It’s gratifying
that HIMSS believes I play some small part in helping the industry
move forward through my efforts to educate policy makers and other
stakeholders about the many benefits of digitized health data.”
The Healthcare Information and Management Systems Society, Inc.
(HIMSS) is a global advisor and thought leader supporting the
transformation of the health ecosystem through information and
technology.
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers to make better decisions and
deliver better care for healthier populations. To learn more, visit
www.allscripts.com, Twitter, YouTube and It
Takes A Community: The Allscripts Blog.
© 2021 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210614005705/en/
Investors: Stephen Shulstein
312-386-6735 Stephen.Shulstein@allscripts.com Media: Concetta Rasiarmos 312-447-2466
concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Apr 2023 to Apr 2024